Chester County News and Community Website
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that it will host a conference call and live webcast Wednesday to discuss its financial results for the fourth quarter …
Verrica Pharmaceuticals Schedules Conference Call to Discuss 2025 Results Read More
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) reported net sales of $98,296,000 for 2025, down from $101,681,000 in 2024, as lower unit volumes weighed on performance.
Omega Flex Reports Lower Sales and Net Income for 2025 Read More
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) reported fourth quarter and full-year 2025 financial results and provided updates on its clinical pipeline, including completion of enrollment for a Phase 3 …
Ocugen Reports 2025 Results and Clinical Progress Across Gene Therapy Pipeline Read More
MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) said it will release financial and operating results for the fourth quarter of 2025 before markets open Tuesday, March 17.
Neuronetics to Report Fourth Quarter 2025 Results March 17 Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) reported full-year revenue of $1.50 billion for 2025, an 11 percent increase from the previous year, as the infrastructure engineering software company …
Bentley Systems Reports $1.5 Billion Revenue for 2025 Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) reported revenue of $1.99 billion from continuing operations for 2025, a 17.2 percent increase from the prior year, as the medical technology company …
Teleflex Reports $1.99 Billion Revenue for 2025, Announces Restructuring Read More
WAYNE, PA — Ecovyst Inc. (NYSE: ECVT) reported fourth-quarter 2025 sales of $199.4 million and net income of $9.2 million, or $0.08 per diluted share, compared with $148.9 million in …
Ecovyst Reports Higher Fourth-Quarter Sales, Lower Net Income Read More
WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) reported its financial results for the fourth quarter and full year of 2025 and provided updates on several clinical-stage drug development programs, …
Aclaris Reports 2025 Financial Results and Clinical Trial Updates Read More
WAYNE, PA — Radian Group Inc. (NYSE: RDN) reported full-year 2025 net income from continuing operations of $618 million, or $4.39 per diluted share, and said it completed the $1.67 …
Radian Reports $618 Million Full-Year Income, Completes Inigo Deal Read More MALVERN, PA — Ocugen Inc. (Nasdaq: OCGN) will host a conference call and live webcast at 8:30 a.m. Eastern on Wednesday, March 4, 2026, to discuss its fourth-quarter and full-year …
Ocugen to Host March 4 Call on Q4 and Full-Year 2025 Results Read More